# TOYO Pharmaceutical Co., Ltd. – FDA Inspection, Jun 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/toyo-pharmaceutical-co-ltd/61a39a53-a2df-4034-88a1-73b0cabcfde6
Source feed: FDA_Inspections

> FDA inspection 1208748 of TOYO Pharmaceutical Co., Ltd., June 16, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208748
- Company Name: TOYO Pharmaceutical Co., Ltd.
- Inspection Date: 2023-06-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1322480 - 2026-06-12](https://www.keypedia.com/records/fda_inspections/toyo-pharmaceutical-co-ltd/899dfea2-731d-48a8-948d-7ac03432d88f)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)

Company: https://www.keypedia.com/companies/toyo-pharmaceutical-co-ltd/21837e65-0d4e-4e06-becd-fd959cccc990

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c